Medtronic plc logo

Medtronic plc (MDT)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
94. 75
-0.7
-0.7334%
After Hours
$
95. 28
+0.53 +0.5594%
122.1B Market Cap
25.14 P/E Ratio
2.84% Div Yield
27.31M Volume
5.2 Eps
$ 95.45
Previous Close
Add Transaction
Day Range
94.17 96.53
Year Range
73.31 106.33
Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

Zacks | 1 year ago
Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic (MDT) concluded the recent trading session at $84.76, signifying a +0.19% move from its prior day's close.

Zacks | 1 year ago
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.

Fool | 1 year ago
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

Medtronic (MDT) reachead $84.30 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.

Zacks | 1 year ago
Medtronic (MDT) Rises But Trails Market: What Investors Should Know

Medtronic (MDT) Rises But Trails Market: What Investors Should Know

The latest trading day saw Medtronic (MDT) settling at $83.75, representing a +0.46% change from its previous close.

Zacks | 1 year ago
Medtronic: Time To Buy This Dividend Aristocrat Bargain

Medtronic: Time To Buy This Dividend Aristocrat Bargain

In recent months, Medtronic has soundly outperformed the S&P 500 index. The company's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Medtronic's interest coverage and net debt to EBITDA ratios are robust.

Seekingalpha | 1 year ago
Medtronic: A Dividend Aristocrat With Stability and Innovation

Medtronic: A Dividend Aristocrat With Stability and Innovation

Investors increasingly seek stable and resilient investments in today's volatile and economically uncertain market. Consequently, it is crucial to identify companies with strong fundamentals, defensive strategies, and dependable shareholder returns.

Marketbeat | 1 year ago
Medtronic: One Of The Best Times To Buy

Medtronic: One Of The Best Times To Buy

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in the cardiovascular, neuromodulation, and diabetes care segments. Medtronic's 3.4% dividend yield is well-supported by earnings, and management continues to invest in R&D to drive shareholder returns. With a forward P/E of 15.1 versus a historical norm of 18.2, MDT is attractively valued amidst improving margins and demographic tailwinds from an aging population.

Seekingalpha | 1 year ago
Medtronic (MDT) Stock Dips While Market Gains: Key Facts

Medtronic (MDT) Stock Dips While Market Gains: Key Facts

Medtronic (MDT) concluded the recent trading session at $82.60, signifying a -0.12% move from its prior day's close.

Zacks | 1 year ago
Tariffs have destroyed trust in the US, former Medtronic CEO says

Tariffs have destroyed trust in the US, former Medtronic CEO says

Bill George, executive fellow at Harvard Business School and former CEO and chairman of Medtronic, joins Market Domination Overtime to discuss the most recent tariff developments. George emphasizes how President Trump's tariff policies and policy adjustments erode other nations' trust in the United States.

Youtube | 1 year ago
Medtronic (MDT) Advances But Underperforms Market: Key Facts

Medtronic (MDT) Advances But Underperforms Market: Key Facts

In the latest trading session, Medtronic (MDT) closed at $88.86, marking a +0.42% move from the previous day.

Zacks | 1 year ago
Why Medtronic Stock Marched Higher on Monday

Why Medtronic Stock Marched Higher on Monday

Medtronic (MDT 2.62%) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value. They liked the medical device specialist's latest piece of news about one of its products, and reacted accordingly.

Fool | 1 year ago
Loading...
Load More